van Dongen, Jacques J.M.
European Scientific foundation for Laboratory Hemato Oncology (ESLHO),
Netherlands
2025 Rank: 26,692
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 872 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26,692 | 20,556 |
| Total Cites | 35,770 | 44,896 |
| H-index | 92 | 104 |
| Hm-index | 28 | 32 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 11 | 18 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 5,327 | 6,373 |
| Number of Single+First+Last Authored Papers | 241 | 241 |
| Total Cites to Single+First+Last Authored Papers | 16,152 | 20,262 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 23,741 | 26,329 |
| Ratio of Total Citations to Distinct Citing Papers | 1.51 | 1.71 |
| Self-Citation Percentage |
20.33%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 880 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26,270 | 19,180 |
| Total Cites | 34,023 | 42,879 |
| H-index | 90 | 103 |
| Hm-index | 27 | 32 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 10 | 17 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 5,098 | 6,124 |
| Number of Single+First+Last Authored Papers | 243 | 243 |
| Total Cites to Single+First+Last Authored Papers | 15,601 | 19,645 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 22,587 | 25,079 |
| Ratio of Total Citations to Distinct Citing Papers | 1.51 | 1.71 |
| Self-Citation Percentage |
20.65%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 862 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25,082 | 19,069 |
| Total Cites | 31,624 | 40,069 |
| H-index | 87 | 99 |
| Hm-index | 27 | 31 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 10 | 17 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 4,822 | 5,826 |
| Number of Single+First+Last Authored Papers | 240 | 240 |
| Total Cites to Single+First+Last Authored Papers | 14,817 | 18,774 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 21,031 | 23,412 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.71 |
| Self-Citation Percentage |
21.08%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 954 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27,899 | 20,156 |
| Total Cites | 26,645 | 33,676 |
| H-index | 81 | 92 |
| Hm-index | 25 | 28 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 6 | 13 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 4,330 | 5,247 |
| Number of Single+First+Last Authored Papers | 226 | 226 |
| Total Cites to Single+First+Last Authored Papers | 13,427 | 17,023 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 17,919 | 19,962 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.69 |
| Self-Citation Percentage |
20.88%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.